Dopamine's Role in Schizophrenia: The Hyperdopaminergia Hypothesis Explained
Dopamine dysregulation is a cornerstone of schizophrenia pathophysiology. The "dopamine hypothesis" has evolved from a simple excess model to a nuanced circuit-based framework.
Regional Dopamine Imbalance
Mesolimbic Pathway (VTA → Nucleus Accumbens)
Hyperdopaminergia in this reward pathway drives positive symptoms (hallucinations, delusions). Antipsychotic D2 receptor blockade here reduces psychosis.
Mesocortical Pathway (VTA → Prefrontal Cortex)
Hypodopaminergia in this cognitive control pathway underlies negative and cognitive symptoms (avolition, working memory deficits). D2 blockade can worsen this; partial agonists (e.g., aripiprazole) or D1 agonists may offer benefit.
Nigrostriatal Pathway
D2 blockade here causes extrapyramidal side effects (EPS) and tardive dyskinesia.
Tuberoinfundibular Pathway
D2 blockade elevates prolactin, leading to endocrine side effects.
Supporting Evidence
- Amphetamine (a dopamine releaser) can induce psychosis in healthy individuals and exacerbate symptoms in patients.
- PET imaging shows elevated striatal dopamine synthesis capacity and D2/3 receptor availability in unmedicated patients.
- Genetic risk variants enrich for dopamine signaling genes (DRD2, COMT, DAT1).
Integrated Models
Current models integrate dopamine with glutamate (NMDA hypofunction → disinhibition of dopamine neurons) and GABA interneuron deficits. Treatment aims to normalize striatal dopamine while preserving or enhancing prefrontal function.
Schizophrenia - Related Articles
- Brain Regions Affected by Schizophrenia: Understanding the Neurological Impact
- PTSD and Schizophrenia: Exploring the Connection
- Understanding Schizophrenia: A Historical and Comprehensive Overview
- Highest-Paying States for Psychiatrists in 2024: Where Compensation Peaks
- Schizophrenia Brain Changes: Prefrontal, Temporal, Hippocampal, and Amygdala Alterations
- Schizophrenia: Separating Medical Reality from Legal Myths
- Narcissism vs. Psychosis: Key Differences in Reality Testing and Treatment
